Results
The remimazolam group showed significantly faster first eye opening time (2.3 [interquartile range, IQR: 1.8–3.3] min vs. 5.0 [IQR: 3.5–7.8] min, median difference:—2.7 [95% confidence interval, CI: -3.7 to -1.5] min, 